1.
Sirirungsri W. Serious Adverse Events Attributed to Nevirapine Regimens for Postexponsure Prophylaxis After HIV Exposures-Worldwide, 1997-2000. J Assoc Med Sci [Internet]. 2015 Feb. 15 [cited 2024 May 18];34(2):131. Available from: https://he01.tci-thaijo.org/index.php/bulletinAMS/article/view/60318